× Main Page Fashion Lifestyle Outdoor Home Travel Real Estate Business

BUSINESS - COMPANY NEWS

Global Foundation for Human Aging Research Contributes $75,000 to Support the Dana-Farber Cancer Institute in its Cellular Aging Research

Friday, December 29, 2017

Dana Farber Cancer Institute

BUSINESS - COMPANY NEWS

Source : Global Foundation for Human Aging Research

Facebook Share Twitter Tweet Google Plus Share

The Global Foundation for Human Aging Research (http://globalhumanaging.org/) announces a donation of $75,000 to Dana-Farber Cancer Institute, the cancer treatment and research center designated by the National Cancer Institute in Boston, MA, and affiliate of Harvard Medical School.

Dr. Vincent Giampapa, the founder of the Global Foundation for Human Aging Research, believes specific nutraceuticals and drugs, as well as DNA segments, can be used to alter the gene activity of both somatic cells and stem cells to make them function more optimally during the aging process. He believes this is critical to extend healthspan and delay the onset of diseases of aging, including cancer. His goal with this donation is to explore that hypothesis.

Dr. Giampapa's colleague, who shares the same vision and enthusiasm for this research, is Wayne Marasco, MD, PHD, Professor of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard University. Dr. Marasco will be directing the planned research.

After meeting with Dr. Marasco, Dr. Giampapa agreed to have the foundation fund research specifically focused on using a unique strain of humanized mice to document the changes in the epigenome in minute detail, so as to be able to evaluate the efficiency of different drugs as well as DNA segments to alter the gene activity of cells to function more optimally during the aging process. The first drug to be tested will be Metformin, which has already shown signs of being a likely candidate for an anti-aging drug therapy in the near future.

"We already know that specific natural compounds and pharmaceuticals can have an impact on cellular aging and function, but the missing information is how they work at the epigenetic level," says Dr. Giampapa.

For its part, the Global Foundation for Human Aging Research envisions the development of novel compounds that are focused on decreasing inflammation, repairing DNA damage, and restoring ideal gene expression at the cellular level. "One mission of the Global Foundation is to fund research that will lead to the identification of compounds that can be used to treat large numbers of aging individuals on a global basis. This can impact the costs of healthcare in a significant way. Prevention and proactivity toward health is what is needed now and in the future," says Dr. Giampapa.





LATEST POSTS
Glosfer, a blockchain company, held the Infinity Project Unpacked Event on 16 December 2017 in Seoul, South Korea.
Two leaders in supersonic technology, Aerion and Lockheed Martin (NYSE: LMT) announced a Memorandum of Understanding (MOU) today to define a formal and gated process to explore the feasibility of a joint development ...
An alluring combination of contemporary geometric lines and subtle design details, the new Studio S collection of bath and shower faucets from American Standard highlights thought-provoking styling and unmatched performance.
Realtor.com today unveiled The Big Move, an original video series that tells the story of a young military family as they search for and make their dream home become a reality.



FEATURED PRODUCTS
#112943601
#112964897
#112986195
#113007495